Evidence map›Paper›PMID 26862784›Full record

ArticleAmerican journal of respiratory and critical care medicine2016

A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β-Catenin.

Zhiqiang Jiang, Taotao Lao, Weiliang Qiu, Francesca Polverino, Kushagra Gupta, Feng Guo, John D Mancini, Zun Zar Chi Naing, Michael H Cho, Peter J Castaldi and 10 more

Erratum issuedAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 84 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Long isoforms of the COPD risk gene FAM13A orchestrate human lung epithelial development.American journal of respiratory cell and molecular biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Developmental Origins of Asthma and COPD.Annual review of physiology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  17. Particulate matter-induced epigenetic modifications and lung complications.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  18. The FAM13A Long Isoform Regulates Cilia Movement and Coordination in Airway Mucociliary Transport.American journal of respiratory cell and molecular biology · 2024
    Article
  19. Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Zhiqiang Jiang1 Channing Division of Network Medicine, Department of Medicine.
Taotao Lao1 Channing Division of Network Medicine, Department of Medicine.
Weiliang Qiu1 Channing Division of Network Medicine, Department of Medicine.
Francesca Polverino2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Kushagra Gupta2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Feng Guo1 Channing Division of Network Medicine, Department of Medicine.
John D Mancini1 Channing Division of Network Medicine, Department of Medicine.
Zun Zar Chi Naing1 Channing Division of Network Medicine, Department of Medicine.
Michael H Cho1 Channing Division of Network Medicine, Department of Medicine.
Peter J Castaldi1 Channing Division of Network Medicine, Department of Medicine.
Yang Sun2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Jane Yu2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Maria E Laucho-Contreras2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Lester Kobzik5 Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; and.
Benjamin A Raby1 Channing Division of Network Medicine, Department of Medicine.
Augustine M K Choi6 Department of Medicine, Weill Cornell Medical College, New York, New York.
Mark A Perrella2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Caroline A Owen2 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Edwin K Silverman1 Channing Division of Network Medicine, Department of Medicine.
Xiaobo Zhou1 Channing Division of Network Medicine, Department of Medicine.
Pulmonary and Critical Care Associates · USBrigham and Women's Hospital · USLovelace Respiratory Research Institute · USCornell University · USGeneral Department of Preventive Medicine · VN

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Systems Biology, Bioinformatics, and BiostatisticsP01HL105339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2011 to 2015
$12.2M
Clinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0M
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTLR01HL124233 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2014 to 2024
$7.1M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Metabolic Control of Stemness in lung epithelial progenitors by FAM13AR01HL127200 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, ANNY XIAOBO · 2015 to 2024
$4.9M
Targeting MMP9 to Improve Outcomes in Serious Influenza InfectionsR01AI111475 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S, LEVY, BRUCE D · 2014 to 2018
$4.3M
Using Networks to Assign Gene Function in Lung DiseaseR01HL111759 · NHLBI · DANA-FARBER CANCER INST · PI QUACKENBUSH, JOHN, SILVERMAN, EDWIN K · 2012 to 2015
$3.4M
Functional Genomic Approaches to Dissect COPD GWAS LociR33HL120794 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K, ZHOU, ANNY XIAOBO · 2016 to 2018
$1.7M
Functional Genomic Approaches to Dissect COPD GWAS LociR21HL120794 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K, ZHOU, ANNY XIAOBO · 2014 to 2015
$478k
Novel Anti-inflammatory Activities For ADAM8 In Pulmonary EmphysemaR21HL111835 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2012 to 2013
$456k
NHLBI NIH HHS P01 HL105339NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL075478NHLBI NIH HHS R01 HL111759NHLBI NIH HHS R01 HL124233NHLBI NIH HHS R01 HL127200NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R21 HL111835NHLBI NIH HHS R21 HL120794NHLBI NIH HHS R33 HL120794NIAID NIH HHS R01 AI111475
6 · The paper itself

Abstract

rationaleA genetic locus within the FAM13A gene has been consistently associated with chronic obstructive pulmonary disease (COPD) in genome-wide association studies. However, the mechanisms by which FAM13A contributes to COPD susceptibility are unknown.

objectivesTo determine the biologic function of FAM13A in human COPD and murine COPD models and discover the molecular mechanism by which FAM13A influences COPD susceptibility.

methodsFam13a null mice (Fam13a(-/-)) were generated and exposed to cigarette smoke. The lung inflammatory response and airspace size were assessed in Fam13a(-/-) and Fam13a(+/+) littermate control mice. Cellular localization of FAM13A protein and mRNA levels of FAM13A in COPD lungs were assessed using immunofluorescence, Western blotting, and reverse transcriptase-polymerase chain reaction, respectively. Immunoprecipitation followed by mass spectrometry identified cellular proteins that interact with FAM13A to reveal insights on FAM13A's function. MEASUREMENTS AND MAIN

resultsIn murine and human lungs, FAM13A is expressed in airway and alveolar type II epithelial cells and macrophages. Fam13a null mice (Fam13a(-/-)) were resistant to chronic cigarette smoke-induced emphysema compared with Fam13a(+/+) mice. In vitro, FAM13A interacts with protein phosphatase 2A and recruits protein phosphatase 2A with glycogen synthase kinase 3β and β-catenin, inducing β-catenin degradation. Fam13a(-/-) mice were also resistant to elastase-induced emphysema, and this resistance was reversed by coadministration of a β-catenin inhibitor, suggesting that FAM13A could increase the susceptibility of mice to emphysema development by inhibiting β-catenin signaling. Moreover, human COPD lungs had decreased protein levels of β-catenin and increased protein levels of FAM13A.

conclusionsWe show that FAM13A may influence COPD susceptibility by promoting β-catenin degradation.

Indexed as

Animalsbeta CateninDisease Models, AnimalFemaleGenetic Predisposition to DiseaseHumansMiceMice, Inbred C57BLMice, KnockoutProtein StabilityPulmonary Disease, Chronic ObstructiveSignal Transductionbeta Catenincell proliferationemphysemaFAM13Aprotein stabilityβ-catenin

Identifiers

PMID26862784
PMCPMC5003213
OpenAlexW2258717577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.